Purpose The purpose of this report was to retrospectively review a series treated with pelvic tumour resection and massive allograft reconstruction, and determine survival of patients and implants, functional results and morbidity of surgical technique. Methods From 1999, 33 patients underwent pelvic tumour resection and massive allograft reconstruction. The mean age was 40 years (range, 14-72) and 29 patients had a primary malignant tumour. The resection involved the acetabular area in all but three patients. Results At a median follow-up of 33 months (range, two-143) four patients had local recurrence. The morbidity was high: five deep infections (15 %), requiring two allograft removal, six hip dislocations (18 %), eight sciatic nerve palsy (24 %), persistent in six cases, and two loosening of the acetabular component. Implant survival was 87.3 % at last follow up. The cumulative overall patient's survival was 41.5 % at five and ten years. The average MSTS functional score was 70 % (range, 54-100 %) when the acetabulum was preserved while it was 61 % (30-100 %) in patients with acetabular resection.
Introduction
Surgical treatment of pelvic tumours is challenging and, due to the complex anatomy of the pelvis, with the proximity of neurovascular structures and viscera, adequate resection margins are not often achieved [1] . With improvements in diagnostic imaging and multimodality treatment including radiation and chemotherapy, limb salvage resection as opposed to amputation represents a reliable surgical option [2] [3] [4] [5] .
Enneking, Erikson and Steel [5] [6] [7] [8] were among the first surgeons to report their results with limb-sparing surgery after excision of a pelvic bone tumour. These procedures were most disabling when the acetabulum was excised. Despite the high morbidity and mortality, these authors demonstrated that limb salvage in pelvic tumours was feasible and that, with adequate surgical margins, a number of patients can survive. Several reconstructive options have been proposed, including ileofemoral or ischiofemoral arthrodesis, massive allografts, custom-made prostheses combined with hip arthroplasty, and saddle or modular hemipelvic prostheses [2-4, 9, 10] . However, in all these reconstructive methods, significant rates of early and late complications were reported. Early complications, as infections and dislocations, might delay adjuvant chemotherapy, with possible negative effects on patient's prognosis. Late complications, as loosening and mechanical failure, usually require surgical revision with the risk of progressive bone loss and functional impairment.
Pelvic massive allografts provide restoration of the anatomical architecture of the pelvis, preserving bone stock and limb length and, when coupled with a hip prosthesis in acetabular resections, allow a satisfactory functional recovery [3, 9, 10] .
The purpose of the present report was to retrospectively review a series of patients treated with pelvic tumour resection and massive allograft reconstruction, with the aim of determining the survival of patients and implants, functional results and morbidity of surgical technique.
Material and methods
Between 1999 and 2011, pelvic resection and allograft reconstruction was performed in 33 patients with pelvic tumors (Table 1 ). There were 21 males and 12 females with a mean age of 40 years (range, 14-72). Diagnosis was chondrosarcoma in 13 patients (two dedifferentiated), Ewing's sarcoma in seven, osteosarcoma in six, giant cell tumour in two (one multicentric), and one case each of the following diagnoses: pleomorphic sarcoma, plasmacitoma, radiotherapy induced sarcoma, metastasis from renal cell carcinoma and neurofibrosarcoma.
According to Enneking and Dunham classification of pelvic resections [5] , three patients (9 %) had type I resection, 15 (46 %) had type I-II, nine (27 %) had a type II resection, four (12 %) had type II-III resection and two (6 %) had a type I-II-III resection (Table 1 ). All patients except three had a resection involving the acetabulum. Surgical margins were classified according to the Musculoskeletal Tumor Society (MSTS) system [11] and they resulted wide in 27 patients, marginal in four and intralesional in two (one in metastatic carcinoma and the other in giant cell tumor).
Seven patients with Ewing's sarcoma and six patients with osteosarcoma were treated with neo-adjuvant and adjuvant chemotherapy. Five patients with Ewing's sarcoma received radiotherapy, three pre-operatively and two postoperatively. One case of plasmacitoma received pre-operative radiotherapy. Four patients (one osteosarcoma, one chondrosarcoma, one pleomorphic sarcoma and one neurofibrosarcoma) received irradation due to local recurrence.
Functional outcome was determined using the MSTS score '93 system [12] , checking six parameters including pain, function, emotional acceptance, supports, walking ability and gait.
Follow-up ranged from two to 143 months, with an average of 33 months, and was calculated from the date of surgery to the date of last consultation or until the patient's death.
All the operations were performed in a single institution, under general anaesthesia, with the patient in lateral decubitus on contralateral side. An iIliofemoral approach described by Enneking et al. was employed [5] .
Fresh-frozen, not irradiated, hemipelvic allografts were used for reconstruction. The graft was obtained under strictly aseptic conditions and stored at −80°C.
Allograft fixation was performed by titanium cannulated screws to fix the sacroiliac joint and the residual pubic branch and a molded reconstruction plate to fix the posterior column (Fig. 1) . In 30 patients the acetabulum was resected and the allograft was implanted together with a total hip prosthesis ( Fig. 2 ) which was reinforced with metallic rings. Cemented self-retaining acetabular components were used in 26 cases while double motility components were preferred in four cases. The prosthetic femoral stem was cemented in 23 patients, uncemented in three, and in four cases the proximal femur was reconstructed with a modular cemented megaprosthesis (Megasystem C®, Waldemar Link, Hamburg, Germany) after hip extra-articular resection because of femoral tumoral extension (with pathological femoral fracture in two cases).
To prevent hip dislocation, when the peri-acetabular area was reconstructed, an articulated pelvic brace was applied for three months after surgery. Partial weightbearing was started six to eight weeks after operation, but full weightbearing was not allowed until three to six months post surgery.
The overall survival of patients and implants was analysed using Kaplan-Meier survival analysis SPSS statistical package (version 20.0; SPSS, Chicago, Illinois). The end point for implant survival was defined as the removal of the allograft for infection or fracture.
Results
At an average follow up of 33 months (range, 2-143), 12 patients (36 %) were alive without disease and six patients (18 %) were alive with disease. Fourteen patients (42 %) had died of the disease and one death was not related to the malignant tumor. In the 29 cases with primary malignant tumor, 13 patients (45 %) died of the disease. Mortality was more frequent in dedifferentiated chondrosarcoma (two patients, 100 %), followed by osteosarcoma (five out of six patients, 83 %), Ewing's sarcoma (three out of seven patients, 43 %) and central chondrosarcoma (two out of 11 patients, 18 %). One case each of the following diagnoses died of the disease: plasmacitoma, renal cell metastatic carcinoma and neurofibrosarcoma.
Of the six patients with osteosarcoma, four patients (67 %) died due to tumour-related causes. One patient had metastasis after local recurrence and died 16 months after surgery. Three patients died after lung metastasis. In one patient, the death was not related to the malignant tumor.
Three patients with Ewing's sarcoma died after metastatic dissemination, two patients were alive with disease and two were alive with no evidence of disease.
Four patients with chondrosarcoma died of disease, two of whom were dedifferentiated. The meaning of the ** is in this types of tumors is not valued necrosis caused by chemotherapy, either because they are chemoresistant as chondrosarcoma or because they do not value the degree of necrosis as prognostic value Eight patients were alive with no evidence of disease and one patient had local recurrence and lung metastases but was alive at last follow-up.
One patient with plasmacitoma died of disseminated disease 58 months after surgery. The patient with neurofibrosarcoma had local recurrence and died 12 months after surgery.
Local recurrence was observed in four patients (12 %): two chondrosarcomas, one osteosarcoma and one neurofibrosarcoma. All patients were treated with radiotherapy and chemotherapy. Three patients died of the disease and one was still alive at last follow up. All these patients underwent a type I-II pelvic resection and the surgical margins were wide in all cases. However, no statistically significant difference in the rate of local recurrence between tumours confined to type I-II resection was found (Fisher's exact test p00.10). Eighteen patients showed lung metastases. The metastatic dissemination rate was 62 % in 29 primary malignant tumor cases. Thirteen patients died of disease, four were alive with disease and one was alive with no evidence of disease after metastasectomy.
The morbidity rate was high. Sciatic nerve palsy occurred in eight patients (24 %), was transient in two cases and persistent with only partial recovery in six cases.
Five patients had deep infection (15 %) that was treated with surgical debridement, irrigation and systemic intravenous antibiotics. The allograft was removed in two patients because of persistent infection, one ending in a flail hip and another retaining the antibiotic-loaded cement spacer in place along with the total hip prosthesis.
Six hip dislocations occurred. Three patients were treated by closed reduction and cast immobilization and in the other three patients surgical revision and open reduction was necessary.
In two cases, loosening of the acetabular component was observed 70 and 80 months after surgery and in both cases surgical revision preserving the original allograft was performed with a double motility component in one case and a self-retaining socket in the other case.
The MSTS score could be determined for 23 patients, because the remaining ten had less than six months of follow up or their general conditions did not allow assessing the items of functional score. In three cases of iliac wing resection and acetabular preservation, the average MSTS functional score was 70 %, ranging from 54 to 100 % while in patients with acetabular resection it was 61 % (30-100 %).
The cumulative overall survival of the patients was 41.4 % at five and ten years.
Considering the different hystological diagnoses, chondrosarcoma patients had the best survival (71 at eight years) while dedifferentiated chondrosarcoma and osteosarcoma had the worse survival (respectively, zero and 17 % at 17 months) (Fig. 3) . The survival of the reconstruction, defined as allograft removal as end point, was 87.3 % at 12 years (Fig. 4) .
Discussion
The prognosis of primary malignant bone tumours is worse in the pelvis than in the appendicular skeleton and it has been correlated to resection margins and to response to adjuvant treatment [13] [14] [15] . The first objective of surgical treatment of pelvic sarcomas must be the removal of the tumor with adequate (tumor free) resection margins. This is often a difficult task, due to the proximity of neurovascular structures and viscera or in cases where the tumor extends through the sacroiliac joint. Recently, the application of navigation systems in tumor surgery of the pelvis and sacrum have allowed application of guided osteotomies and have shown to be helpful in achieving safe resection margins [16] . In our series, 14 % (4/29) of patients with a primary malignant pelvic tumor had local recurrence, although a wide surgical margin had been achieved in all of them. The local recurrence rate was comparable with literature reports ranging from 9.6 to 33 % [3, 9, 10, [17] [18] [19] .
After surgical removal of pelvic sarcoma, the type of reconstruction should be planned considering the different histology. Chondrosarcoma usually occurs in adult patients and no adjuvant therapies are required routinely. Osteosarcoma and Ewing's sarcoma usually occur in young patients and their prognosis is severe and strictly correlated to tumoral response to chemotherapy. In these cases, the morbidity of the reconstructive technique might interfere and delay postoperative chemotherapy with possible negative influence on patients' survival. The complication rate after removal of a pelvic tumor and reconstruction with pelvic allografts or prostheses is high, ranging from 30 to 90 % [3, 9, 10, [18] [19] [20] [21] . For this reason, biologic solutions using ileofemoral or ischiofemoral arthrodesis have been proposed, providing an acceptable function with a low complication rate and limb shortening that may be compensated with a shoe lift or subsequent limb lengthening [14, 15] .
Several reconstructive methods following pelvic tumor resection have been discussed and no standard procedure has been defined so far. Many authors [9, 17] have demonstrated that patients with a stable, reconstructed pelvis have better MSTS functional scores than patients without pelvis reconstruction.
When part of the ilium could be preserved (Type II-III), saddle prostheses have been used with poor long-term results due to excessive instability and progressive reabsorption of the residual iliac bone [4, 20] . Recently, stemmed cups with innovative designs have been introduced for acetabular reconstruction in bone tumor surgery [22] . The major concern of these implants is the risk of primary instability of the hip which can be addressed using large femoral heads and a synthetic mesh (Trevira tube) [19, 22] . Another possible reconstruction is to use the autologous proximal femur, rotated on its vascular pedicle, fixed to residual ileum and pubis and coupled with a cemented total hip prosthesis [23] .
After pelvic resection with complete removal of the iliac wing and acetabulum (Type I-II), one reconstructive option called "hip transposition" was recently described. The femoral head is transposed to the sacral wing and secured by a Trevira tube. The authors reported satisfactory functional results with the major disadvantage of limb-length discrepancy [19, 24] .
Custom-made pelvic prostheses, manufactured using preoperative imaging data, may present a mismatching after resection when a more extensive resection than planned is required [21] . For this reason, modular pelvic prostheses have been proposed, with the chance to adapt prosthetic assembling on the basis of a definitive extension of resection [17] . The major concern regarding pelvic prostheses is primary stability and the risk of long-term loosening of the implant. Dislocation rate has been reported to range from 3.5 to 20 % and better stability was achieved after introduction of large-size heads [17, 18, 21] . A prosthetic survival of 42 % at five years was reported by Ozaki et al., and in the experience of Jaiswal et al. the revision rate was 24, 35 and 49 % at five, ten and 20 years [18, 21] .
Massive allografts with total hip prosthesis represent a valid reconstructive option after pelvic tumor resection, allowing bone stock restoration and satisfactory functional recovery. Sciatic nerve palsy was the most frequent surgical complication in our series with a prevalence of 24 %, transient in two cases and persistent with only partial recovery in six cases. In the literature, the neurological deficit after pelvic resection was frequently reported and it was described for both the femoral and sciatic nerve in up to 30 % of cases [3, 9, [17] [18] [19] [20] . Deep infection is a frequent complication in pelvic tumor reconstructive surgery (ranging from 12 to 36 %) [3, 9, 10, [17] [18] [19] [20] [21] [22] due to the proximity of the perineum and bowels, the large surgical exposure and the prolonged operative time in patients often immunosuppressed. The infection rate in our study was 15 %, and two out of five patients required surgical revision with allograft removal for persistent infection.
Due to the massive bone and muscular resection in pelvic tumor surgery, primary instability is a relevant issue in every reconstructive technique. In our series, snap-fit or selfretaining cemented acetabular components were used in all but four cases where a double motility implant was employed. In spite of this, dislocation occurred in six cases (20 %), which was a higher rate than reported by others (from zero to 15 %) [3, 9, 10, 25] . In our series, no augmentation with artificial ligaments or synthetic mesh was used to improve primary stability, as suggested in other reports.
The overall implant survival with allograft removal as endpoint was 87.3 % at 12 years, and functional results, following the MSTS'93 system, scored an average of 61 %, which is comparable to the functional score reported with both pelvic allografts or prostheses and hip transposition (48-73 %) [3, 9, 10, 17, 19, 21, 24, 25] .
The main limitation of this study is that it is a retrospective study of a series of cases of pelvic tumours not homogeneous in histological diagnosis, but pelvic tumours are rare and all other series of pelvic allografts reported in literature consider different diagnosis.
The results of the present study show that pelvic allografts represent a valid option for reconstruction after resection of pelvic tumours. However, the prognosis of pelvic osteosarcoma and Ewing's sarcoma is severe and, considering that postoperative morbidity might interfere with adjuvant treatments, such a demanding reconstructive procedure should be reserved for non metastatic patients with a good imaging response to pre-operative chemotherapy. In metastatic patients or when a poor response to pre-operative chemotherapy is observed at imaging, biologic reconstructive procedures like iliofemoral or ischiofemoral arthrodesis may be considered when feasible, in order to have a low risk of postoperative morbidity and the best chance for an early delivery of adjuvant therapies. Massive allograft reconstruction seems to be indicated in pelvic chondrosarcoma since the survival is better than in other pelvic malignancies and no adjuvant chemotherapy or radiotherapy is routinely required.
